Stay updated with breaking news from Lightdeck Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- LightDeck Diagnostics, the company leveraging planar waveguide technology to deliver lab-quality diagnostics in minutes, today announced it has...
The firm will develop a rapid test for its LightDeck analyzer to detect C-reactive proteins, inducible-proteins 10 (IP-10 or CXCL-10), and other inflammatory markers.
The company has now raised approximately $45.75 million in venture-capital funds, according to previous SEC disclosures. It’s unclear for what those funds will be used. The company did not respond to a request for comment Thursday. BOULDER — LightDeck Diagnostics, a firm building equipment for rapid diagnosis of COVID-19 and other illnesses, has raised an additional $9.9 million. The Boulder company raised those funds by selling a combination of equity and future warrants, according to a disclosure to the U.S. Securities and Exchange Commission this week. The funds were reported by Mbio...